Literature DB >> 2944130

Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington's disease.

P R Sanberg, M A Henault, A W Deckel.   

Abstract

Huntington's disease is characterized by gross degeneration of the intrinsic neurons of the striatum, restless hyperkinetic choreiform movements and dementia. Rats which received injections of kainic acid have provided an extremely viable model for this extrapyramidal movement disorder. The present preliminary report investigated the effects of multiple homotopic transplantations of normal fetal Day 17 striatal ridge tissue into the lesioned striatum of male kainic acid-treated rats. Nine weeks after transplantation, the spontaneous nocturnal hyperkinetic locomotor abnormalities as measured by horizontal activity and total distance travelled were attenuated in the striatal transplanted animals compared to sciatic nerve transplanted controls. Similarly, the exacerbated response to d-amphetamine exhibited by the animal model was attenuated in the striatal transplanted animals. The striatal transplants reconstructed much of the gross morphology of the lesioned striatum, although acetylcholinesterase was found to be reduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944130     DOI: 10.1016/0091-3057(86)90269-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease.

Authors:  P Hantraye; D Riche; M Maziere; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.

Authors:  Jodi L McBride; Shilpa Ramaswamy; Mehdi Gasmi; Raymond T Bartus; Christopher D Herzog; Eugene P Brandon; Lili Zhou; Mark R Pitzer; Elizabeth M Berry-Kravis; Jeffrey H Kordower
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

3.  Recovery of behavioral functions following the transplantation of the embryonal striatum into the damaged amygdala of the rat brain.

Authors:  I V Ermakova; V V Zhulin
Journal:  Neurosci Behav Physiol       Date:  1996 Jan-Feb

4.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

Authors:  T B Freeman; F Cicchetti; R A Hauser; T W Deacon; X J Li; S M Hersch; G M Nauert; P R Sanberg; J H Kordower; S Saporta; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Intrastriatal grafts derived from fetal striatal primordia. III. Induction of modular patterns of fos-like immunoreactivity by cocaine.

Authors:  F C Liu; S B Dunnett; H A Robertson; A M Graybiel
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Embryonic striatal grafts reverse the disinhibitory effects of ibotenic acid lesions of the ventral striatum.

Authors:  P J Reading; S B Dunnett
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

7.  Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern.

Authors:  L Björklund; I Strömberg
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

8.  Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat.

Authors:  R Barker; S B Dunnett
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  A primate model of Huntington's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen.

Authors:  O Isacson; D Riche; P Hantraye; M V Sofroniew; M Maziere
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

10.  Restoration of the striatal circuitry: from developmental aspects toward clinical applications.

Authors:  Marie-Christin Pauly; Tobias Piroth; Máté Döbrössy; Guido Nikkhah
Journal:  Front Cell Neurosci       Date:  2012-04-19       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.